Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis
Authors:
Open Access
- 5 May 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 145 (1) , 93-100
Abstract
Summary: Primary biliary cirrhosis (PBC) is an autoimmune disorder that specifically destroys biliary epithelial cells (BECs). In patients with PBC, the immunodominant pyruvate dehydrogenase complex E2 component (PDC-E2), identified as an antigen for disease-specific anti-mitochondrial antibody, is expressed aberrantly in the BEC cytoplasm. The present study focused on the pathophysiological role of aberrant PDC-E2 in the development of PBC. The BEC-specific cytokeratin-19 promoter and PDC-E2 gene were cloned from a mouse cDNA library. The constructed transgene was microinjected into fertilized eggs of mice, and the offspring were identified by Southern blotting and reverse transcriptase–polymerase chain reaction. The protein expression was confirmed by immunoprecipitation, immunoblotting and immunohistochemical staining. Five founder lines were identified as carrying the PDC-E2 gene, and one of these lines expressed PDC-E2 mRNA. The protein expression of exogenous PDC-E2 was detected in the liver. The transgenic mouse line showed diffuse expression of PDC-E2 in the BEC cytoplasm. Biochemical, serological and histological features of PBC were not detected. We established transgenic mice that constitutively express PDC-E2. The results indicated that aberrant PDC-E2 expression in the cytoplasm of BECs is not sufficient for the initiation of autoimmunity. Additional factors may be required to establish a model of PBC.Keywords
This publication has 57 references indexed in Scilit:
- The Immune Response to Mitochondrial AutoantigensSeminars in Liver Disease, 2005
- Molecular cloning, and characterization and expression of dihydrolipoamide acetyltransferase component of murine pyruvate dehydrogenase complex in bile duct cancer cellsJournal of Gastroenterology, 2002
- Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis11Edited by J. KarnJournal of Molecular Biology, 2001
- T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis*1Hepatology, 1995
- Molecular mimicry in halothane hepatitis: Biochemical and structural characterization of lipoylated autoantigensToxicology, 1995
- Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosisHepatology, 1994
- Nonsuppurative cholangitis is induced in neonatally thymectomized mice: A possible animal model for primary biliary cirrhosisHepatology, 1994
- Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitisHepatology, 1991
- Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosisHepatology, 1989
- Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissuesEuropean Journal of Cancer and Clinical Oncology, 1987